131 related articles for article (PubMed ID: 11253117)
1. Successful xenografting of cryopreserved primary pancreatic cancers.
Sorio C; Bonora A; Orlandini S; Moore PS; Capelli P; Cristofori P; Dal Negro G; Marchiori P; Gaviraghi G; Falconi M; Pederzoli P; Zamboni G; Scarpa A
Virchows Arch; 2001 Feb; 438(2):154-8. PubMed ID: 11253117
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
3. [The establishment of a human pancreatic mixed ductal-endocrine carcinoma cell line].
Hou M; Gao J; Liu T; Cui Q
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):422-6. PubMed ID: 11869555
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice.
Reyes G; Villanueva A; García C; Sancho FJ; Piulats J; Lluís F; Capellá G
Cancer Res; 1996 Dec; 56(24):5713-9. PubMed ID: 8971180
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
6. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
[TBL] [Abstract][Full Text] [Related]
7. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
8. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.
Moore PS; Sipos B; Orlandini S; Sorio C; Real FX; Lemoine NR; Gress T; Bassi C; Klöppel G; Kalthoff H; Ungefroren H; Löhr M; Scarpa A
Virchows Arch; 2001 Dec; 439(6):798-802. PubMed ID: 11787853
[TBL] [Abstract][Full Text] [Related]
9. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
10. Xenografting and harvesting human ductal pancreatic adenocarcinomas for DNA analysis.
Walter K; Eshleman J; Goggins M
Methods Mol Med; 2005; 103():103-11. PubMed ID: 15542900
[TBL] [Abstract][Full Text] [Related]
11. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
12. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.
Matsubayashi H; Watanabe H; Nishikura K; Ajioka Y; Kijima H; Saito T
Cancer; 1998 Feb; 82(4):651-60. PubMed ID: 9477096
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neuroendocrine tumors of the pancreas by real-time quantitative polymerase chain reaction. A methodological approach.
Annaratone L; Volante M; Asioli S; Rangel N; Bussolati G
Endocr Pathol; 2013 Jun; 24(2):83-91. PubMed ID: 23657967
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
15. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
16. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas.
Yachida S; Zhong Y; Patrascu R; Davis MB; Morsberger LA; Griffin CA; Hruban RH; Laheru D; Iacobuzio-Donahue CA
Pancreas; 2011 Aug; 40(6):905-10. PubMed ID: 21768923
[TBL] [Abstract][Full Text] [Related]
18. Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras.
Löhr M; Müller P; Zauner I; Schmidt C; Trautmann B; Thévenod F; Capellá G; Farré A; Liebe S; Jesenofsky R
Virchows Arch; 2001 Jun; 438(6):581-90. PubMed ID: 11469690
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas.
Ceha HM; Clement MJ; Polak MM; Offerhaus GJ; Slebos RJ
Pancreas; 1998 Jul; 17(1):85-8. PubMed ID: 9667525
[TBL] [Abstract][Full Text] [Related]
20. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]